本页面由Tiger Trade Technology Pte. Ltd.提供服务

Amneal Pharmaceuticals, Inc.

20.03
+0.12000.60%
盘后:20.150.1200+0.60%19:50 EDT
成交量:458.82万
成交额:9,188.43万
市值:63.90亿
市盈率:41.66
高:20.28
开:20.04
低:19.86
收:19.91
52周最高:21.18
52周最低:9.56
股本:3.19亿
流通股本:1.91亿
量比:1.31
换手率:2.40%
股息:- -
股息率:- -
每股收益(TTM):0.4808
每股收益(LYR):0.2200
净资产收益率:613.02%
总资产收益率:8.60%
市净率:193.48
市盈率(LYR):91.05

数据加载中...

2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/08/05

重要事件披露

Form 8-K - Current report
2025/08/01

重要事件披露

Form 8-K - Current report